Fred Alger Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-37,718
| Closed | -$2.84M | – | 575 |
|
|
2022
Q2 | $2.84M | Sell |
37,718
-708
| -2% | -$53.3K | 0.01% | 313 |
|
|
2022
Q1 | $1.03M | Sell |
38,426
-189
| -0.5% | -$5.08K | ﹤0.01% | 385 |
|
|
2021
Q4 | $1.84M | Sell |
38,615
-1,266
| -3% | -$60.4K | ﹤0.01% | 363 |
|
|
2021
Q3 | $2.65M | Sell |
39,881
-22,305
| -36% | -$1.48M | 0.01% | 331 |
|
|
2021
Q2 | $4.85M | Sell |
62,186
-1,520
| -2% | -$119K | 0.01% | 298 |
|
|
2021
Q1 | $6.03M | Sell |
63,706
-875
| -1% | -$82.8K | 0.02% | 288 |
|
|
2020
Q4 | $7.87M | Sell |
64,581
-27,777
| -30% | -$3.38M | 0.02% | 251 |
|
|
2020
Q3 | $8.07M | Buy |
92,358
+13,788
| +18% | +$1.2M | 0.02% | 215 |
|
|
2020
Q2 | $5.08M | Buy |
78,570
+25,458
| +48% | +$1.64M | 0.02% | 226 |
|
|
2020
Q1 | $2.37M | Sell |
53,112
-7,026
| -12% | -$314K | 0.01% | 259 |
|
|
2019
Q4 | $3.75M | Buy |
60,138
+10,138
| +20% | +$631K | 0.01% | 252 |
|
|
2019
Q3 | $1.88M | Buy |
50,000
+10,000
| +25% | +$376K | 0.01% | 288 |
|
|
2019
Q2 | $1.63M | Buy |
+40,000
| New | +$1.63M | 0.01% | 304 |
|